decreased tumor growth/size_Adam9<tm1Bbl>/Adam9<tm1Bbl>

http://metadb.riken.jp/0003447I129SvAdam9tm1BblAdam9tm1BblAdam9tm1Bbl

decreased tumor growth/size_Adam9<tm1Bbl>/Adam9<tm1Bbl>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• a disintegrin and metallopeptidase domain 9 (meltrin gamma)
  http://metadb.riken.jp/db/mgi_rdf/MGI:105376

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Adam9<tm1Bbl>/Adam9<tm1Bbl>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Adam9<tm1Bbl>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129/Sv

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased tumor growth/size
  http://purl.obolibrary.org/obo/MP_0003447

文献

http://purl.org/net/cito/citesAsAuthority

• Victor. Guaiquil, et.al., ADAM9 is involved in pathological retinal neovascularization., Molecular and cellular biology, 2009, 29
  http://rdf.ncbi.nlm.nih.gov/pubmed/19273593